Filtered By:
Management: Government
Vaccination: Cancer Vaccines
This page shows you your search results in order of date.
Order by Relevance | Date
Total 101 results found since Jan 2013.
Prevention and control of HPV and HPV-related cancers in France: the evolving landscape and the way forward - a meeting report
This report covers some critical findings, key challenges, and future steps to improve the status of HPV prevention and control measures in the country.PMID:37537651 | DOI:10.1186/s12919-023-00271-0
Source: Cancer Control - August 3, 2023 Category: Cancer & Oncology Authors: Dur-E-Nayab Waheed Catherine Weil Olivier Didier Riethmuller Eduardo L Franco Jean Luc Pr étet Marc Baay Nubia Munoz Alex Vorsters Source Type: research
Frequency of health care provider recommendations for HPV vaccination: a survey in three large cities in China
DISCUSSION: The frequency of HCPs' recommendations for HPV vaccination in China was much lower than that in many developed countries. To enhance the recommendation frequency, medical institutions should help HCPs gain more knowledge of HPV and master communication skills. At the same time, the government should take measures to enhance the accessibility of HPV vaccines. The media should help to alleviate people's concerns and encourage them to face up sexual health.PMID:37497028 | PMC:PMC10366465 | DOI:10.3389/fpubh.2023.1203610
Source: Cancer Control - July 27, 2023 Category: Cancer & Oncology Authors: Yimeng Mao Yuchen Zhao Lingyun Zhang Jie Li Abu S Abdullah Pinpin Zheng Fan Wang Source Type: research
Managing the transition in cervical screening methods for Taiwan: Policy recommendations and perspectives
J Formos Med Assoc. 2023 Jul 12:S0929-6646(23)00246-2. doi: 10.1016/j.jfma.2023.06.018. Online ahead of print.ABSTRACTSince government-provided annual cervical cytology testing for all Taiwanese women aged 30 years or older became available in 1995, both cervical cancer incidence and death have decreased significantly. However, with the 2018 introduction of the national immunization program for human papillomavirus (HPV) vaccination in all schoolgirls aged 13-15 years old, the positive predictive value of cytology testing is expected to decrease with rising vaccination rates, and therefore a transition to more sensitive HP...
Source: J Formos Med Assoc - July 14, 2023 Category: General Medicine Authors: Chien-Chin Chen Chyong-Huey Lai Chih-Long Chang Wen-Fang Cheng Raoh-Fang Pwu Jane Tsai Peng-Hui Wang Jacqueline Whang-Peng Gi-Ming Lai Source Type: research
How Taiwan has responded to COVID-19 and how COVID-19 has affected Taiwan, 2020-2022
J Microbiol Immunol Infect. 2023 Apr 6:S1684-1182(23)00078-6. doi: 10.1016/j.jmii.2023.04.001. Online ahead of print.ABSTRACTFrom January 2020 to December 2022, there was a total of 8,872,955 confirmed COVID-19 cases in Taiwan. In addition, a total of 15,253 COVID-19 related deaths were reported. During these three years, the government and health authority did many efforts to response this pandemic. In the early pandemic, Taiwan Central Epidemic Command Center was established in the early 2020 to organize associated resource, develop effective policy and implement strict intervention. In response to COVID-19 pandemic, man...
Source: Cancer Control - April 15, 2023 Category: Cancer & Oncology Authors: Chih-Cheng Lai Ping-Ing Lee Po-Ren Hsueh Source Type: research
Nationwide introduction of HPV vaccine in Zimbabwe 2018-2019: Experiences with multiple cohort vaccination delivery
PLOS Glob Public Health. 2022 Apr 6;2(4):e0000101. doi: 10.1371/journal.pgph.0000101. eCollection 2022.ABSTRACTThe World Health Organization (WHO) recommends the human papillomavirus (HPV) vaccine for girls aged 9-14 years for cervical cancer prevention and encourages vaccinating multiple cohorts in the first year to maximize impact. The HPV vaccine was introduced nationwide in Zimbabwe in 2018 through a 1-week school-based campaign to multiple cohorts (all girls 10-14 years old), followed by a single cohort (grade 5 girls in school and age 10 girls out-of-school) in 2019. During the 2019 campaign, the multiple cohort's se...
Source: Cancer Control - March 24, 2023 Category: Cancer & Oncology Authors: Julie Garon Carlton Joan Marembo Portia Manangazira Maxwell Rupfutse Adelaide Shearley Egnes Makwabarara Anna Hidle Anagha Loharikar Source Type: research
Retrieving Billions in Overpayments by CMS
This article focuses on the relatively young technologies that enable CMS to uncover overbillings, whether they be errors or fraud. The article is based on an interview with Kel Pults, chief clinical officer and vice president of MediQuant. A future article will explain how Medicare Advantage plans are trying to improving data collection and reporting, and how AI helps.
Challenges of Investigating Overpayments
Undeserved payments are needles lurking in the haystack of 135 million Americans enrolled in Medicare, Medicaid, and the Children’s Health Insurance Program (CHIP). But the needles pile up fast. Improper payments f...
Source: EMR and HIPAA - February 17, 2023 Category: Information Technology Authors: Andy Oram Tags: AI/Machine Learning Analytics/Big Data Health IT Company Healthcare IT Regulations Revenue Cycle Management #COVID19 CMS COVID Reimbursement Healthcare AI Healthcare Analytics Kel Pults MAOs Medicare Advantage MediQuant Overp Source Type: blogs
Weekly Overseas Health IT Links – 15th October, 2022.
This article uses the one that divides providers into groups depending on the life cycle stage the clinic is at the given moment. According to this classification, medical providers fall into three groups:BeginnersGrowing clinicsWell-established providersHealth care providers are business entities, so their life cycle, like that of any business, consists of the early stage or launch, growth and maturity. At each stage, providers have different priorities and goals, and the choice of medical software solutions should be made accordingly.Medical software for beginnersThe launch phase can be tough. At this stage, the profits ...
Source: Australian Health Information Technology - October 15, 2022 Category: Information Technology Authors: Dr David G More MB PhD Source Type: blogs
Weekly Overseas Health IT Links –1st October, 2022.
This article details information required for integration into EHRs to build personalized treatment plans and develop successful SDOH programs that provide resources and support for patients in need. In addition, successful SDOH programs implemented by Kaiser Permanente and Boston Medical Center showcase how supporting clinicians with real-time SDOH data can lead to patient-centric care. Create a 360-Degree Patient View Through TechnologyThe Office of the National Coordinator for Health Information Technology (ONC)indicatesthat the “collection, documentation, reporting, access, and use of SDOH data … can be used t...
Source: Australian Health Information Technology - October 1, 2022 Category: Information Technology Authors: Dr David G More MB PhD Source Type: blogs
The Evolution of Medical Countermeasures for Ebola Virus Disease: Lessons Learned and Next Steps
Vaccines (Basel). 2022 Jul 29;10(8):1213. doi: 10.3390/vaccines10081213.ABSTRACTThe Ebola virus disease outbreak that occurred in Western Africa from 2013-2016, and subsequent smaller but increasingly frequent outbreaks of Ebola virus disease in recent years, spurred an unprecedented effort to develop and deploy effective vaccines, therapeutics, and diagnostics. This effort led to the U.S. regulatory approval of a diagnostic test, two vaccines, and two therapeutics for Ebola virus disease indications. Moreover, the establishment of fieldable diagnostic tests improved the speed with which patients can be diagnosed and publi...
Source: Cancer Control - August 26, 2022 Category: Cancer & Oncology Authors: Ian Crozier Kyla A Britson Daniel N Wolfe John D Klena Lisa E Hensley John S Lee Larry A Wolfraim Kimberly L Taylor Elizabeth S Higgs Joel M Montgomery Karen A Martins Source Type: research
The Macro View – Health, Economics, and Politics and the Big Picture. What I Am Watching Here And Abroad.
August 04, 2022 Edition-----The war seems to grind on sadly and Pres. Biden is having a second round with COVID as unprecedented weather happens all over the US. It all feels rather like ‘the end of days’!In the UK we see an increasing chance of a third female PM being elected as the country seems to be struggling. We do need to remember however the UK remains a significant power with nuclear weapons and home-grown nuclear submarines!In OZ we have had last week working out how to progress the First Nations ‘Voice’ as we wrap up the 1st session of Parliament for the new Government. Comments welcome on how you think ...
Source: Australian Health Information Technology - August 4, 2022 Category: Information Technology Authors: Dr David G More MB PhD Source Type: blogs
Weekly Australian Health IT Links – 25 July, 2022.
Here are a few I have come across the last week or so. Note: Each link is followed by a title and a few paragraphs. For the full article click on the link above title of the article. Note also that full access to some links may require site registration or subscription payment.General Comment-----Quite a lot going on this week and we have had a pretty busy comment flow on the blog. Interesting how comment streams evolve!The telehealth debate continues and the Government is yet to notice what a ‘steaming pile of poo’the #myHR is!-----https://www.healthcareitnews.com/news/anz/australia-launches-digital-cancer-hub-childre...
Source: Australian Health Information Technology - July 25, 2022 Category: Information Technology Authors: Dr David G More MB PhD Source Type: blogs
The cost-effectiveness of human papillomavirus vaccination in the Philippines
Vaccine. 2022 May 20:S0264-410X(22)00609-0. doi: 10.1016/j.vaccine.2022.05.025. Online ahead of print.ABSTRACTCervical cancer is the second most common cancer among women in the Philippines. Human papillomavirus (HPV) vaccination provides protection from the most common cancer-causing HPV types. This analysis used a proportionate outcomes model to estimate the potential cost-effectiveness of four different HPV vaccine products-Cervarix™, Cecolin®, GARDASIL®, and GARDASIL®9-for routine HPV vaccination of 10 cohorts of 9-year-old girls from the government and societal perspectives. Model parameters included cervical can...
Source: Cancer Control - May 23, 2022 Category: Cancer & Oncology Authors: Cecilia L Llave Maria Esterlita V Uy Hilton Y Lam Josephine G Aldaba Clarence C Yacapin Michelle B Miranda Haidee A Valverde Wilda T Silva Saira Nawaz Rose C Slavkovsky Jessica Mooney Elisabeth L Vodicka Source Type: research
